These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29809231)

  • 21. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
    Fillenbaum GG; Mohs R
    J Alzheimers Dis; 2023; 93(1):1-27. PubMed ID: 36938738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of age, education and gender in the Consortium to Establish a Registry for the Alzheimer's Disease (CERAD)-Neuropsychological Assessment Battery for Cantonese-speaking Chinese elders.
    Liu KP; Kuo MC; Tang KC; Chau AW; Ho IH; Kwok MP; Chan WC; Choi RH; Lam NC; Chu MM; Chu LW
    Int Psychogeriatr; 2011 Dec; 23(10):1575-81. PubMed ID: 21729408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontotemporal dementia: patient characteristics, cognition, and behaviour.
    Diehl J; Kurz A
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):914-8. PubMed ID: 12325050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention and CERAD test performances in cognitively impaired elderly subjects.
    Verhülsdonk S; Hellen F; Höft B; Supprian T; Lange-Asschenfeldt C
    Acta Neurol Scand; 2015 Jun; 131(6):364-71. PubMed ID: 25352352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dementia, mild cognitive impairment and quantitative EEG in patients with Parkinson's disease.
    Fonseca LC; Tedrus GM; Letro GH; Bossoni AS
    Clin EEG Neurosci; 2009 Jul; 40(3):168-72. PubMed ID: 19715179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A parsimonious scoring and normative calculator for the Parkinson's disease mild cognitive impairment battery.
    Bezdicek O; Sulc Z; Nikolai T; Stepankova H; Kopecek M; Jech R; Růžička E
    Clin Neuropsychol; 2017; 31(6-7):1231-1247. PubMed ID: 28276860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dementia and mild cognitive impairment in patients with Parkinson's disease.
    Tedrus GM; Fonseca LC; Letro GH; Bossoni AS; Samara AB
    Arq Neuropsiquiatr; 2009 Jun; 67(2B):423-7. PubMed ID: 19623438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
    Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Utility of the Envelope Task in Mild Cognitive Impairment and Dementia.
    Marcone S; Gagnon JF; Lecomte S; Imbeault H; Limoges F; Postuma RB; Bertrand JA; Joubert S; Rouleau I
    Can J Neurol Sci; 2017 Jan; 44(1):9-16. PubMed ID: 27665668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Korean Addenbrooke's Cognitive Examination for diagnosing Alzheimer's dementia and mild cognitive impairment in the Korean elderly.
    Heo JH; Lee KM; Park TH; Ahn JY; Kim MK
    Appl Neuropsychol Adult; 2012; 19(2):127-31. PubMed ID: 23373580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
    J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.